tag bayer 
The Pharma Data
MARCH 16, 2022
The Bayer Foundation has presented the Hansen Family Award, complete with its prize money of EUR 75,000, to Professor Kai Johnsson. using SNAP-tag) involves labeling cell proteins with a fluorescent dye, thereby enabling researchers to observe how proteins interact in the living cell and where in the cell they are located.
Pharmaceutical Technology
MAY 15, 2023
Innovation S-curve for the pharmaceutical industry Peptide nano-particle conjugates is a key innovation area in the pharmaceutical industry By tagging peptides with nanoparticles, peptide nano-particle conjugates allow enhanced control over their biological behaviour, overcoming intrinsic limitations of the individual materials.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
FEBRUARY 8, 2024
Along with the hefty price tag for screen time that may not be perceived to be a worthwhile investment, and despite favoring advertising at other major events like the Grammys, pharma tends to stay somewhat clear of all the Super Bowl hoopla. Bayer is preparing to file for FDA approval based on strong Phase III data it shared last month.
Delveinsight
DECEMBER 3, 2020
It has been speculated that modifications to the epigenome drive cell ageing, especially a process known as DNA methylation, by which methyl groups are tagged onto DNA. Bayer creates cell and gene therapy platform. Bayer has made a cell and gene therapy platform to assist its growing pipeline of advanced therapy medicinal products.
XTalks
MARCH 22, 2023
2014 saw multiple business unit buyouts in the industry, with Novartis acquiring GlaxoSmithKline’s oncology arm and Bayer taking over Merck’s consumer health business. In addition, nearly half of all new drugs launched between 2020 and 2021 came with a price tag of $150,000 per year, or more. In 2015, Pfizer acquired Hospira.
Drug Discovery World
NOVEMBER 9, 2023
Novel platforms This session will begin with chariperson’s remarks from Lars Linden, PhD, Vice President, Head, Biologics Research, Bayer HealthCare, which will be followed by a keynote presentation by Agnieszka Kielczewska, PhD, Director, Research, Antibody Discovery and Screening, Biologics Discovery, Amgen.
pharmaphorum
NOVEMBER 28, 2022
Substra is the software that powered the MELLODDY platform, a collaboration in which Amgen, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, GSK, Janssen, Merck, Novartis, and Servier all agreed to share drug discovery data — but not with each other directly, nor with Owkin.
Expert insights. Personalized for you.
52 
Let's personalize your content